建立Vantive

建立Vantive

建议的肾脏护理分离  

We began the journey to establish our chronic kidney care and acute therapies businesses into one standalone company in January 2023. 拟议中的与百特的分离将建立万维, a new standalone company with an impressive 70 years of experience and a single focus on advancing therapies and services for kidney care and other vital organ support. 直到拟议的分离完成, our 肾脏保健 group will continue to do business as Baxter. 
基督牙齿头像

The energy and excitement our organization has toward building a new kidney and critical care company based on a 70-year legacy of pioneering therapy in this space is truly electrifying. Our new brand is coming to life through our teams’ steadfast commitment to helping patients lead full and meaningful lives in partnership with our healthcare customers. We are eager to continue collaborating with the kidney and critical care communities to help transform care.

克里斯•托斯, 执行副总裁兼集团总裁, 肾脏保健; designated CEO, 拟定的肾脏护理公司

致力于ladbrokes立博体育的患者和客户

Vantive will continue to serve as a trusted partner to providers and clinicians, focusing on improving outcomes for the more than one million patients we serve every year around the world. We are driven by the role we play in helping patients and their healthcare teams. Their determination inspires us to continually deliver new and bold technologies that will empower them and help to transform chronic kidney care and acute therapies. While we continue to advance the separation activities, we are still operating as Baxter. ladbrokes立博体育正在努力无缝地分离ladbrokes立博体育的业务, ladbrokes立博体育会及时向患者提供相关信息, 客户和其他利益相关者.  

阅读更多关于ladbrokes立博体育的旅程

Baxter Announces Strategic Actions to Enhance Operational Effectiveness, Accelerate Innovation for 病人 and Drive Value for Shareholders

百特任命克里斯·托斯为肾护理公司的首席执行官

Baxter Announces Vantive as the Name of Proposed 肾脏保健 Spinoff

医护人员在病房里读着一张图表

Vantive(建议肾护理独立公司)

~$4.2023年营收将达到50亿美元

>22,000 Employees*

 

Vantive will build on Baxter’s nearly 70-year commitment to pioneering therapies for kidney patients and providers across modalities. Products will include peritoneal dialysis devices and solutions; connected technologies like the Sharesource remote patient management system; organ support therapies including continuous 肾 replacement therapy; and hemodialysis filters and systems.

*截至23年12月31日的员工人数

 

了解更多关于ladbrokes立博体育的肾脏护理业务:

百特的肾脏护理业务

一位妇女在诊所接受血液透析治疗

分销商更新 & 供应商

Until the proposed separation is complete, Baxter will continue to operate as one organization. 您的百特联系人保持不变. 经销商协议仍然有效. We are committed to continuing to deliver the same level of support you receive today. ladbrokes立博体育正在努力无缝地分离ladbrokes立博体育的业务, ladbrokes立博体育将酌情向合作伙伴提供最新情况.  

一名妇女在床上进行腹膜透析治疗

投资者最新资讯 

The proposed separation is expected to create value for all of our stakeholders, 包括百特的股东.